Integra Lifesciences Holdings Corp
NASDAQ:IART
Integra Lifesciences Holdings Corp
Operating Income
Integra Lifesciences Holdings Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
Operating Income
$271.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
22%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Integra Lifesciences Holdings Corp's Operating Income?
Operating Income
271.8m
USD
Based on the financial report for Dec 31, 2023, Integra Lifesciences Holdings Corp's Operating Income amounts to 271.8m USD.
What is Integra Lifesciences Holdings Corp's Operating Income growth rate?
Operating Income CAGR 10Y
22%
Over the last year, the Operating Income growth was -7%. The average annual Operating Income growth rates for Integra Lifesciences Holdings Corp have been 7% over the past three years , 3% over the past five years , and 22% over the past ten years .